| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Integrins | 88 | 2024 | 838 | 11.520 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 136 | 2018 | 379 | 9.590 |
Why?
|
| Cell Adhesion | 161 | 2024 | 3089 | 6.780 |
Why?
|
| Intercellular Adhesion Molecule-1 | 79 | 2018 | 1131 | 5.610 |
Why?
|
| von Willebrand Factor | 20 | 2022 | 680 | 5.510 |
Why?
|
| Antigens, Surface | 117 | 2001 | 1616 | 4.090 |
Why?
|
| Cell Adhesion Molecules | 82 | 2013 | 1610 | 3.370 |
Why?
|
| Protein Structure, Tertiary | 76 | 2013 | 3751 | 3.280 |
Why?
|
| Protein Conformation | 69 | 2024 | 3946 | 3.280 |
Why?
|
| Ligands | 82 | 2024 | 3274 | 3.180 |
Why?
|
| Models, Molecular | 73 | 2021 | 5382 | 3.020 |
Why?
|
| Binding Sites | 74 | 2023 | 6001 | 2.680 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 16 | 2013 | 577 | 2.630 |
Why?
|
| Macrophage-1 Antigen | 48 | 2021 | 283 | 2.570 |
Why?
|
| Integrin alphaXbeta2 | 13 | 2013 | 28 | 2.540 |
Why?
|
| Leukocytes | 34 | 2017 | 2030 | 2.500 |
Why?
|
| Integrin alpha5beta1 | 4 | 2022 | 36 | 2.210 |
Why?
|
| Protein Binding | 75 | 2024 | 9301 | 2.130 |
Why?
|
| Transforming Growth Factor beta1 | 6 | 2023 | 637 | 2.070 |
Why?
|
| Protein Structure, Secondary | 31 | 2023 | 1211 | 2.010 |
Why?
|
| Amino Acid Sequence | 99 | 2021 | 13400 | 1.930 |
Why?
|
| Cell Movement | 55 | 2018 | 5196 | 1.860 |
Why?
|
| L-Selectin | 20 | 2006 | 212 | 1.850 |
Why?
|
| Protein Folding | 18 | 2020 | 868 | 1.780 |
Why?
|
| Integrin alpha4beta1 | 9 | 2022 | 119 | 1.650 |
Why?
|
| Protozoan Proteins | 6 | 2023 | 843 | 1.620 |
Why?
|
| Chemokines, CXC | 16 | 2006 | 417 | 1.620 |
Why?
|
| Antigens, CD | 43 | 2005 | 4025 | 1.600 |
Why?
|
| Chemotaxis, Leukocyte | 23 | 2001 | 657 | 1.600 |
Why?
|
| Antibodies, Monoclonal | 140 | 2021 | 9237 | 1.570 |
Why?
|
| Lymphocytes | 53 | 2013 | 2602 | 1.560 |
Why?
|
| Cell Membrane | 36 | 2023 | 3635 | 1.540 |
Why?
|
| Fibronectins | 15 | 2022 | 721 | 1.510 |
Why?
|
| Molecular Sequence Data | 93 | 2013 | 17597 | 1.510 |
Why?
|
| Magnesium | 16 | 2018 | 815 | 1.470 |
Why?
|
| K562 Cells | 18 | 2021 | 644 | 1.460 |
Why?
|
| Disulfides | 24 | 2022 | 461 | 1.420 |
Why?
|
| Endothelium, Vascular | 36 | 2011 | 4423 | 1.370 |
Why?
|
| Crystallography, X-Ray | 31 | 2019 | 1947 | 1.370 |
Why?
|
| Protein Multimerization | 8 | 2023 | 959 | 1.360 |
Why?
|
| Neutrophils | 47 | 2006 | 3771 | 1.330 |
Why?
|
| Leukocyte Rolling | 7 | 2010 | 69 | 1.320 |
Why?
|
| Integrin beta Chains | 6 | 2024 | 116 | 1.320 |
Why?
|
| Selectins | 8 | 2008 | 101 | 1.310 |
Why?
|
| Cell Line | 108 | 2018 | 15546 | 1.300 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 22 | 2017 | 694 | 1.280 |
Why?
|
| CHO Cells | 34 | 2024 | 1373 | 1.270 |
Why?
|
| Antigens, Differentiation | 21 | 2001 | 920 | 1.250 |
Why?
|
| P-Selectin | 17 | 2006 | 598 | 1.210 |
Why?
|
| Microscopy, Electron | 19 | 2018 | 2543 | 1.200 |
Why?
|
| Allosteric Regulation | 15 | 2018 | 425 | 1.130 |
Why?
|
| Cytoskeleton | 5 | 2021 | 1179 | 1.130 |
Why?
|
| Dimerization | 23 | 2012 | 881 | 1.130 |
Why?
|
| Manganese | 11 | 2018 | 395 | 1.130 |
Why?
|
| Blood Platelets | 13 | 2022 | 2464 | 1.120 |
Why?
|
| Jurkat Cells | 10 | 2021 | 738 | 1.110 |
Why?
|
| Plasmodium berghei | 4 | 2023 | 161 | 1.080 |
Why?
|
| Cricetinae | 37 | 2013 | 2413 | 1.050 |
Why?
|
| Talin | 3 | 2024 | 47 | 1.030 |
Why?
|
| Protein Structure, Quaternary | 10 | 2018 | 423 | 1.020 |
Why?
|
| Epidermal Growth Factor | 9 | 2012 | 697 | 1.020 |
Why?
|
| Protein Precursors | 6 | 2018 | 1133 | 1.020 |
Why?
|
| Membrane Glycoproteins | 32 | 2010 | 3692 | 1.000 |
Why?
|
| Immunoglobulins | 13 | 2013 | 853 | 0.990 |
Why?
|
| Fibrinogen | 11 | 2012 | 894 | 0.970 |
Why?
|
| Complement C3b | 7 | 2021 | 94 | 0.970 |
Why?
|
| Malaria Vaccines | 2 | 2020 | 165 | 0.960 |
Why?
|
| Epitopes | 45 | 2013 | 2523 | 0.950 |
Why?
|
| Sequence Homology, Amino Acid | 28 | 2018 | 2743 | 0.940 |
Why?
|
| Kinetics | 35 | 2021 | 6273 | 0.930 |
Why?
|
| HEK293 Cells | 16 | 2018 | 4263 | 0.900 |
Why?
|
| Integrin alpha1 | 3 | 2011 | 13 | 0.890 |
Why?
|
| Sporozoites | 4 | 2023 | 83 | 0.880 |
Why?
|
| Membrane Fusion | 5 | 2021 | 264 | 0.880 |
Why?
|
| Protein Subunits | 14 | 2010 | 940 | 0.860 |
Why?
|
| Transfection | 43 | 2012 | 5739 | 0.860 |
Why?
|
| Animals | 238 | 2024 | 168800 | 0.840 |
Why?
|
| Malaria | 4 | 2021 | 1246 | 0.830 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2023 | 71 | 0.820 |
Why?
|
| TGF-beta Superfamily Proteins | 1 | 2022 | 2 | 0.790 |
Why?
|
| Signal Transduction | 33 | 2024 | 23605 | 0.790 |
Why?
|
| Receptors, Lymphocyte Homing | 13 | 2003 | 141 | 0.780 |
Why?
|
| Cell Biology | 1 | 2022 | 91 | 0.760 |
Why?
|
| Recombinant Proteins | 32 | 2021 | 6493 | 0.740 |
Why?
|
| Immunoglobulin Fab Fragments | 10 | 2017 | 443 | 0.740 |
Why?
|
| Calcium | 24 | 2013 | 5770 | 0.740 |
Why?
|
| Sequence Alignment | 20 | 2020 | 2174 | 0.730 |
Why?
|
| Germ Cells | 2 | 2022 | 646 | 0.730 |
Why?
|
| Cystine | 3 | 2021 | 96 | 0.720 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 4 | 2019 | 144 | 0.720 |
Why?
|
| Integrin beta3 | 5 | 2009 | 120 | 0.710 |
Why?
|
| ADAM Proteins | 3 | 2012 | 243 | 0.710 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 26 | 2001 | 893 | 0.710 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2022 | 447 | 0.700 |
Why?
|
| E-Selectin | 13 | 1999 | 576 | 0.690 |
Why?
|
| Mucoproteins | 4 | 2013 | 49 | 0.690 |
Why?
|
| Rhinovirus | 9 | 1998 | 210 | 0.680 |
Why?
|
| von Willebrand Diseases | 4 | 2022 | 135 | 0.650 |
Why?
|
| Glycoproteins | 27 | 2001 | 2196 | 0.640 |
Why?
|
| T-Lymphocytes | 51 | 2011 | 10260 | 0.640 |
Why?
|
| Antigens, Neoplasm | 9 | 2023 | 1996 | 0.640 |
Why?
|
| Humans | 366 | 2024 | 766117 | 0.640 |
Why?
|
| Integrin alphaVbeta3 | 3 | 2012 | 102 | 0.640 |
Why?
|
| Actins | 8 | 2022 | 2061 | 0.640 |
Why?
|
| Algal Proteins | 1 | 2018 | 7 | 0.630 |
Why?
|
| Membrane Proteins | 30 | 2012 | 7850 | 0.630 |
Why?
|
| Spores | 1 | 2018 | 14 | 0.630 |
Why?
|
| Immunoprecipitation | 6 | 2006 | 874 | 0.630 |
Why?
|
| Integrin alpha4 | 6 | 2013 | 89 | 0.620 |
Why?
|
| Metals | 2 | 2022 | 709 | 0.620 |
Why?
|
| Chemotactic Factors | 8 | 1999 | 196 | 0.620 |
Why?
|
| Viral Envelope Proteins | 1 | 2022 | 639 | 0.610 |
Why?
|
| Chlamydomonas reinhardtii | 1 | 2018 | 35 | 0.610 |
Why?
|
| Antibodies | 21 | 2020 | 2415 | 0.610 |
Why?
|
| Receptors, Complement | 18 | 2000 | 240 | 0.600 |
Why?
|
| Awards and Prizes | 1 | 2022 | 365 | 0.600 |
Why?
|
| Cytoplasm | 11 | 2006 | 1498 | 0.580 |
Why?
|
| Transforming Growth Factor beta | 3 | 2023 | 1996 | 0.580 |
Why?
|
| Amino Acid Substitution | 18 | 2013 | 1742 | 0.570 |
Why?
|
| Cations, Divalent | 9 | 2007 | 167 | 0.570 |
Why?
|
| Mice | 142 | 2024 | 81839 | 0.570 |
Why?
|
| Structure-Activity Relationship | 22 | 2008 | 3051 | 0.560 |
Why?
|
| Cricetulus | 10 | 2024 | 807 | 0.560 |
Why?
|
| Recombinant Fusion Proteins | 20 | 2020 | 3733 | 0.560 |
Why?
|
| Drug Design | 1 | 2022 | 1040 | 0.560 |
Why?
|
| Chemokines | 8 | 1998 | 959 | 0.550 |
Why?
|
| Plasmodium | 3 | 2023 | 248 | 0.540 |
Why?
|
| Myostatin | 1 | 2018 | 129 | 0.540 |
Why?
|
| Factor VIII | 1 | 2019 | 347 | 0.530 |
Why?
|
| Hemostasis | 5 | 2019 | 467 | 0.530 |
Why?
|
| Amino Acid Motifs | 12 | 2012 | 924 | 0.520 |
Why?
|
| Binding Sites, Antibody | 14 | 2021 | 340 | 0.520 |
Why?
|
| Receptors, Virus | 9 | 1998 | 651 | 0.500 |
Why?
|
| Cells, Cultured | 53 | 2018 | 18967 | 0.500 |
Why?
|
| Granulocytes | 15 | 1999 | 548 | 0.500 |
Why?
|
| Antibody Specificity | 12 | 2024 | 1061 | 0.480 |
Why?
|
| Mutation | 45 | 2023 | 30209 | 0.480 |
Why?
|
| Nervous System | 1 | 2018 | 542 | 0.480 |
Why?
|
| Molecular Conformation | 9 | 2012 | 539 | 0.480 |
Why?
|
| Mutagenesis, Site-Directed | 12 | 2018 | 1677 | 0.470 |
Why?
|
| Cytotoxicity, Immunologic | 27 | 1995 | 1346 | 0.470 |
Why?
|
| Macrophages | 33 | 2022 | 5776 | 0.470 |
Why?
|
| Models, Biological | 22 | 2019 | 9445 | 0.470 |
Why?
|
| B-Lymphocytes | 22 | 1999 | 4782 | 0.460 |
Why?
|
| Protein Stability | 2 | 2013 | 576 | 0.460 |
Why?
|
| Palatine Tonsil | 8 | 2002 | 193 | 0.460 |
Why?
|
| X-Ray Diffraction | 5 | 2018 | 413 | 0.450 |
Why?
|
| Immunologic Deficiency Syndromes | 14 | 1993 | 547 | 0.450 |
Why?
|
| Stress, Mechanical | 15 | 2019 | 1670 | 0.450 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2024 | 2677 | 0.440 |
Why?
|
| Chemokine CXCL12 | 14 | 2011 | 455 | 0.430 |
Why?
|
| Eosinophils | 5 | 1999 | 946 | 0.430 |
Why?
|
| Flow Cytometry | 36 | 2008 | 5881 | 0.430 |
Why?
|
| Biophysics | 3 | 2012 | 375 | 0.420 |
Why?
|
| Tetradecanoylphorbol Acetate | 14 | 2011 | 822 | 0.420 |
Why?
|
| Oligopeptides | 8 | 2022 | 1195 | 0.420 |
Why?
|
| Surface Plasmon Resonance | 10 | 2007 | 268 | 0.420 |
Why?
|
| Complement System Proteins | 7 | 2012 | 716 | 0.420 |
Why?
|
| Microscopy | 1 | 2018 | 900 | 0.410 |
Why?
|
| Cysteine | 6 | 2010 | 898 | 0.400 |
Why?
|
| Chromatography, Affinity | 8 | 2001 | 521 | 0.400 |
Why?
|
| Carrier Proteins | 6 | 2018 | 4910 | 0.400 |
Why?
|
| Antigens | 12 | 2020 | 1437 | 0.400 |
Why?
|
| Culicidae | 2 | 2023 | 111 | 0.390 |
Why?
|
| Phosphatidylinositols | 8 | 1995 | 276 | 0.390 |
Why?
|
| Pseudopodia | 3 | 2013 | 168 | 0.380 |
Why?
|
| Calcium-Binding Proteins | 5 | 2012 | 1077 | 0.380 |
Why?
|
| Immunological Synapses | 1 | 2011 | 58 | 0.380 |
Why?
|
| Phosphotransferases | 1 | 2012 | 302 | 0.380 |
Why?
|
| Monocytes | 23 | 2004 | 2591 | 0.380 |
Why?
|
| Peptide Fragments | 17 | 2012 | 5126 | 0.380 |
Why?
|
| Polysaccharides | 8 | 2022 | 1017 | 0.380 |
Why?
|
| Receptors, Fibronectin | 4 | 2001 | 37 | 0.380 |
Why?
|
| Lymphocyte Activation | 35 | 2012 | 5503 | 0.370 |
Why?
|
| Hybridomas | 11 | 2002 | 442 | 0.370 |
Why?
|
| Epitope Mapping | 7 | 2004 | 300 | 0.370 |
Why?
|
| Plasmodium falciparum | 5 | 2020 | 1737 | 0.370 |
Why?
|
| Hematopoietic Stem Cells | 11 | 2020 | 3405 | 0.360 |
Why?
|
| T-Lymphocytes, Cytotoxic | 23 | 2001 | 1801 | 0.360 |
Why?
|
| Antibody Affinity | 4 | 2010 | 251 | 0.360 |
Why?
|
| Receptors, CXCR4 | 9 | 2003 | 729 | 0.360 |
Why?
|
| Deuterium Exchange Measurement | 2 | 2022 | 31 | 0.350 |
Why?
|
| Umbilical Veins | 11 | 2002 | 422 | 0.350 |
Why?
|
| Allergy and Immunology | 2 | 2002 | 170 | 0.350 |
Why?
|
| Bone Marrow Cells | 9 | 1999 | 2411 | 0.350 |
Why?
|
| Macrophage Inflammatory Proteins | 4 | 1998 | 121 | 0.340 |
Why?
|
| Interleukin-1 | 8 | 2011 | 1242 | 0.340 |
Why?
|
| Microglia | 2 | 2018 | 1371 | 0.340 |
Why?
|
| Complement C3 | 4 | 2012 | 424 | 0.340 |
Why?
|
| Cell Communication | 11 | 2012 | 1660 | 0.340 |
Why?
|
| Protein Engineering | 6 | 2010 | 550 | 0.340 |
Why?
|
| Receptors, Cell Surface | 5 | 2012 | 2815 | 0.330 |
Why?
|
| Ions | 3 | 2022 | 254 | 0.330 |
Why?
|
| Mechanical Phenomena | 2 | 2019 | 142 | 0.330 |
Why?
|
| Arterioles | 1 | 2010 | 251 | 0.330 |
Why?
|
| Binding, Competitive | 24 | 2004 | 1140 | 0.330 |
Why?
|
| Extracellular Matrix | 7 | 2007 | 1727 | 0.320 |
Why?
|
| Endothelium, Lymphatic | 3 | 2003 | 63 | 0.320 |
Why?
|
| Allosteric Site | 5 | 2011 | 106 | 0.320 |
Why?
|
| Computer Simulation | 5 | 2008 | 6254 | 0.320 |
Why?
|
| Chemokine CCL2 | 5 | 1998 | 602 | 0.320 |
Why?
|
| Antigens, CD34 | 5 | 1998 | 656 | 0.320 |
Why?
|
| Receptors, Immunologic | 14 | 1994 | 1416 | 0.320 |
Why?
|
| Microscopy, Fluorescence | 8 | 2017 | 2627 | 0.310 |
Why?
|
| Mucins | 5 | 2021 | 568 | 0.310 |
Why?
|
| T-Lymphocyte Subsets | 5 | 1998 | 1814 | 0.310 |
Why?
|
| Cloning, Molecular | 15 | 1996 | 4163 | 0.300 |
Why?
|
| Integrin alphaV | 2 | 2024 | 54 | 0.300 |
Why?
|
| Interferon-gamma | 13 | 2011 | 3159 | 0.300 |
Why?
|
| Immunoglobulin Subunits | 1 | 2007 | 1 | 0.300 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 10 | 1997 | 218 | 0.290 |
Why?
|
| Interleukin-8 | 7 | 2019 | 699 | 0.280 |
Why?
|
| Erythrocytes | 12 | 2013 | 2394 | 0.280 |
Why?
|
| Molecular Weight | 26 | 1995 | 2161 | 0.280 |
Why?
|
| Blood Coagulation | 2 | 2010 | 1169 | 0.280 |
Why?
|
| Receptors, Very Late Antigen | 4 | 1995 | 74 | 0.280 |
Why?
|
| Histocompatibility Antigens | 15 | 1987 | 479 | 0.280 |
Why?
|
| Movement | 2 | 2012 | 1461 | 0.270 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 2019 | 2476 | 0.270 |
Why?
|
| Golgi Apparatus | 3 | 2019 | 405 | 0.270 |
Why?
|
| Thermodynamics | 5 | 2012 | 577 | 0.270 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 3 | 1998 | 780 | 0.270 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 20 | 2004 | 1724 | 0.270 |
Why?
|
| Sequence Deletion | 9 | 2018 | 1494 | 0.270 |
Why?
|
| Extracellular Matrix Proteins | 5 | 1998 | 833 | 0.260 |
Why?
|
| Directed Molecular Evolution | 4 | 2014 | 167 | 0.260 |
Why?
|
| Integrin alpha Chains | 2 | 2004 | 93 | 0.260 |
Why?
|
| Immunotherapy | 1 | 2022 | 4746 | 0.260 |
Why?
|
| DNA, Complementary | 6 | 2005 | 1984 | 0.250 |
Why?
|
| Repetitive Sequences, Amino Acid | 3 | 2002 | 91 | 0.250 |
Why?
|
| Biophysical Phenomena | 3 | 2021 | 318 | 0.250 |
Why?
|
| Immunoglobulin G | 17 | 2006 | 4556 | 0.250 |
Why?
|
| Static Electricity | 2 | 2019 | 258 | 0.250 |
Why?
|
| Detergents | 10 | 2011 | 235 | 0.250 |
Why?
|
| Heparin | 2 | 2007 | 1635 | 0.240 |
Why?
|
| Multigene Family | 4 | 2011 | 1081 | 0.240 |
Why?
|
| Cell Aggregation | 10 | 2003 | 238 | 0.240 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 1998 | 353 | 0.240 |
Why?
|
| Cations | 4 | 2010 | 239 | 0.230 |
Why?
|
| Phospholipids | 1 | 2008 | 776 | 0.230 |
Why?
|
| Malaria, Falciparum | 2 | 2012 | 1073 | 0.230 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 4 | 1995 | 1621 | 0.230 |
Why?
|
| Receptors, Chemokine | 5 | 2002 | 651 | 0.230 |
Why?
|
| Receptors, HIV | 4 | 1997 | 159 | 0.230 |
Why?
|
| Solubility | 12 | 2007 | 1077 | 0.230 |
Why?
|
| Glycolipids | 5 | 1995 | 202 | 0.230 |
Why?
|
| Base Sequence | 20 | 2003 | 12405 | 0.230 |
Why?
|
| Hemorheology | 2 | 2010 | 144 | 0.230 |
Why?
|
| Chemokines, CC | 3 | 2002 | 285 | 0.220 |
Why?
|
| Hydrogen Bonding | 3 | 2022 | 290 | 0.220 |
Why?
|
| Proteins | 5 | 2006 | 5995 | 0.220 |
Why?
|
| Fluorescent Antibody Technique | 20 | 2004 | 2469 | 0.220 |
Why?
|
| Mutation, Missense | 1 | 2013 | 2590 | 0.220 |
Why?
|
| Rosette Formation | 11 | 1994 | 152 | 0.220 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 3 | 1998 | 812 | 0.220 |
Why?
|
| Antibodies, Neutralizing | 1 | 2013 | 2011 | 0.220 |
Why?
|
| Archaeal Proteins | 2 | 2002 | 57 | 0.210 |
Why?
|
| Antigen-Antibody Complex | 10 | 2006 | 508 | 0.210 |
Why?
|
| Tumor Cells, Cultured | 15 | 2019 | 6102 | 0.210 |
Why?
|
| Conserved Sequence | 6 | 2004 | 1159 | 0.210 |
Why?
|
| Leukocytes, Mononuclear | 5 | 2006 | 1852 | 0.210 |
Why?
|
| Platelet Activating Factor | 3 | 1998 | 142 | 0.210 |
Why?
|
| Biomimetic Materials | 1 | 2004 | 170 | 0.210 |
Why?
|
| Peptide Library | 1 | 2024 | 351 | 0.210 |
Why?
|
| von Willebrand Disease, Type 2 | 1 | 2022 | 8 | 0.210 |
Why?
|
| Collagen Type IV | 1 | 2023 | 124 | 0.210 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 4959 | 0.200 |
Why?
|
| Heterocyclic Compounds | 1 | 2004 | 245 | 0.200 |
Why?
|
| Endothelium | 6 | 1995 | 768 | 0.200 |
Why?
|
| Micelles | 4 | 2011 | 190 | 0.200 |
Why?
|
| Precipitin Tests | 9 | 2003 | 812 | 0.200 |
Why?
|
| Peptides | 8 | 2018 | 4338 | 0.200 |
Why?
|
| Toxoplasma | 1 | 2023 | 158 | 0.200 |
Why?
|
| Viral Fusion Proteins | 1 | 2022 | 100 | 0.200 |
Why?
|
| Edetic Acid | 7 | 2002 | 274 | 0.200 |
Why?
|
| History, 21st Century | 3 | 2022 | 1574 | 0.190 |
Why?
|
| Enzyme Activation | 5 | 2018 | 3584 | 0.190 |
Why?
|
| Laminin | 1 | 2003 | 404 | 0.190 |
Why?
|
| Receptors, Leukocyte-Adhesion | 2 | 1993 | 53 | 0.190 |
Why?
|
| Receptors, Complement 3b | 7 | 1994 | 124 | 0.190 |
Why?
|
| Down-Regulation | 4 | 2006 | 2927 | 0.190 |
Why?
|
| Drugs, Investigational | 1 | 2003 | 211 | 0.190 |
Why?
|
| Platelet Membrane Glycoproteins | 4 | 1995 | 282 | 0.190 |
Why?
|
| Glycosylation | 8 | 2018 | 1099 | 0.180 |
Why?
|
| Solvents | 1 | 2022 | 299 | 0.180 |
Why?
|
| Spleen | 16 | 1995 | 2294 | 0.180 |
Why?
|
| HLA Antigens | 12 | 1986 | 1338 | 0.180 |
Why?
|
| Tumor Necrosis Factor-alpha | 12 | 2001 | 4342 | 0.180 |
Why?
|
| Amino Acids | 9 | 2004 | 1710 | 0.180 |
Why?
|
| Macromolecular Substances | 11 | 2002 | 1430 | 0.180 |
Why?
|
| Sheep | 9 | 2013 | 1445 | 0.180 |
Why?
|
| Hydrodynamics | 1 | 2021 | 163 | 0.180 |
Why?
|
| Fucose | 2 | 2018 | 115 | 0.180 |
Why?
|
| Urea | 3 | 2022 | 449 | 0.180 |
Why?
|
| Histocompatibility Antigens Class II | 11 | 1986 | 1441 | 0.180 |
Why?
|
| Cell Surface Extensions | 2 | 2012 | 65 | 0.170 |
Why?
|
| Receptors, Colony-Stimulating Factor | 3 | 1995 | 51 | 0.170 |
Why?
|
| Hematopoietic Cell Growth Factors | 3 | 1995 | 98 | 0.170 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 2 | 2002 | 178 | 0.170 |
Why?
|
| Calorimetry | 2 | 2012 | 132 | 0.170 |
Why?
|
| Serine | 2 | 2022 | 828 | 0.170 |
Why?
|
| Gels | 2 | 2021 | 420 | 0.170 |
Why?
|
| rap1 GTP-Binding Proteins | 3 | 2004 | 51 | 0.170 |
Why?
|
| Pulmonary Fibrosis | 1 | 2023 | 503 | 0.160 |
Why?
|
| Cross-Linking Reagents | 3 | 2012 | 687 | 0.160 |
Why?
|
| History, 20th Century | 4 | 2011 | 2762 | 0.160 |
Why?
|
| Mast Cells | 3 | 1995 | 1404 | 0.160 |
Why?
|
| Mutagenesis | 7 | 2011 | 1227 | 0.160 |
Why?
|
| Carbohydrates | 3 | 1998 | 387 | 0.160 |
Why?
|
| Phagocytosis | 8 | 2012 | 1518 | 0.160 |
Why?
|
| Neuraminidase | 6 | 1998 | 190 | 0.160 |
Why?
|
| Microvilli | 4 | 2003 | 234 | 0.160 |
Why?
|
| Antigen-Antibody Reactions | 13 | 2006 | 340 | 0.160 |
Why?
|
| Hybrid Cells | 9 | 1988 | 420 | 0.160 |
Why?
|
| Oligosaccharides | 3 | 1998 | 406 | 0.160 |
Why?
|
| Type C Phospholipases | 3 | 1995 | 284 | 0.160 |
Why?
|
| Osteonectin | 2 | 1996 | 33 | 0.150 |
Why?
|
| Receptors, Fc | 9 | 1995 | 537 | 0.150 |
Why?
|
| Receptors, Lipoprotein | 1 | 1998 | 88 | 0.150 |
Why?
|
| Tolloid-Like Metalloproteinases | 1 | 2018 | 7 | 0.150 |
Why?
|
| DNA | 11 | 2008 | 7193 | 0.150 |
Why?
|
| Anopheles | 1 | 2020 | 193 | 0.150 |
Why?
|
| Isoantigens | 6 | 1985 | 562 | 0.150 |
Why?
|
| Antigens, Bacterial | 3 | 2019 | 1147 | 0.150 |
Why?
|
| Protein Denaturation | 2 | 2012 | 240 | 0.150 |
Why?
|
| Furin | 1 | 2018 | 44 | 0.150 |
Why?
|
| COS Cells | 6 | 2010 | 1135 | 0.150 |
Why?
|
| Temperature | 7 | 2012 | 2227 | 0.140 |
Why?
|
| Green Fluorescent Proteins | 3 | 2017 | 2062 | 0.140 |
Why?
|
| Search Engine | 1 | 2018 | 142 | 0.140 |
Why?
|
| Models, Chemical | 2 | 2010 | 607 | 0.140 |
Why?
|
| Fluorescence Polarization | 1 | 2017 | 140 | 0.140 |
Why?
|
| Enzyme Precursors | 2 | 2006 | 165 | 0.140 |
Why?
|
| Cell Size | 2 | 1996 | 626 | 0.140 |
Why?
|
| Mutant Proteins | 3 | 2009 | 487 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 29 | 2020 | 22341 | 0.140 |
Why?
|
| Chromosome Mapping | 6 | 1996 | 4617 | 0.140 |
Why?
|
| Microscopy, Video | 4 | 2008 | 241 | 0.140 |
Why?
|
| Hemoglobinuria, Paroxysmal | 2 | 1988 | 86 | 0.140 |
Why?
|
| Tenascin | 1 | 1997 | 61 | 0.140 |
Why?
|
| Interleukin-4 | 2 | 1998 | 1149 | 0.140 |
Why?
|
| Cell Line, Transformed | 6 | 2001 | 858 | 0.140 |
Why?
|
| Receptors, Cytoadhesin | 1 | 1996 | 8 | 0.140 |
Why?
|
| Venules | 2 | 1996 | 161 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 1996 | 340 | 0.130 |
Why?
|
| RNA, Messenger | 16 | 2001 | 12775 | 0.130 |
Why?
|
| Cytokines | 8 | 1997 | 7426 | 0.130 |
Why?
|
| Rheology | 5 | 1998 | 347 | 0.130 |
Why?
|
| Immunoglobulin Light Chains | 3 | 1983 | 289 | 0.130 |
Why?
|
| Receptors, Antigen, B-Cell | 3 | 1998 | 545 | 0.130 |
Why?
|
| Water | 1 | 2022 | 1416 | 0.130 |
Why?
|
| Fibrosis | 1 | 2023 | 2073 | 0.130 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2004 | 1962 | 0.130 |
Why?
|
| Stromal Cells | 4 | 1997 | 1332 | 0.130 |
Why?
|
| Helicobacter pylori | 1 | 2019 | 380 | 0.130 |
Why?
|
| Neoplasms | 3 | 2022 | 22344 | 0.130 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2019 | 3678 | 0.130 |
Why?
|
| Lectins | 3 | 2008 | 487 | 0.130 |
Why?
|
| Helicobacter Infections | 1 | 2019 | 390 | 0.130 |
Why?
|
| Transendothelial and Transepithelial Migration | 2 | 2013 | 100 | 0.120 |
Why?
|
| Rats | 30 | 2012 | 23717 | 0.120 |
Why?
|
| Immunization | 1 | 2020 | 1218 | 0.120 |
Why?
|
| Fluorescent Dyes | 2 | 2018 | 1928 | 0.120 |
Why?
|
| Point Mutation | 5 | 2008 | 1591 | 0.120 |
Why?
|
| Genetic Variation | 3 | 2005 | 6612 | 0.120 |
Why?
|
| Macrophage Activation | 7 | 1986 | 553 | 0.120 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2003 | 2879 | 0.120 |
Why?
|
| Antigens, Ly | 6 | 1983 | 297 | 0.120 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 1995 | 614 | 0.120 |
Why?
|
| Chemokine CCL4 | 4 | 1998 | 124 | 0.120 |
Why?
|
| Phylogeny | 3 | 2018 | 2838 | 0.120 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 6 | 1989 | 304 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 18 | 2003 | 6215 | 0.120 |
Why?
|
| Viruses | 1 | 1998 | 371 | 0.110 |
Why?
|
| Stem Cell Factor | 4 | 1995 | 194 | 0.110 |
Why?
|
| DNA Primers | 4 | 2004 | 2824 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2011 | 3801 | 0.110 |
Why?
|
| Tensile Strength | 2 | 2010 | 332 | 0.110 |
Why?
|
| Opsonin Proteins | 4 | 1993 | 138 | 0.110 |
Why?
|
| Disease Models, Animal | 3 | 2023 | 18321 | 0.110 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2009 | 501 | 0.110 |
Why?
|
| Receptors, Antigen | 1 | 1993 | 51 | 0.110 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 1998 | 1656 | 0.110 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1995 | 433 | 0.110 |
Why?
|
| Genes | 7 | 1995 | 1824 | 0.100 |
Why?
|
| Hyaluronic Acid | 1 | 1996 | 483 | 0.100 |
Why?
|
| Up-Regulation | 5 | 2006 | 4133 | 0.100 |
Why?
|
| Endoplasmic Reticulum | 1 | 2019 | 1132 | 0.100 |
Why?
|
| Dithiothreitol | 2 | 2002 | 92 | 0.100 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2012 | 1527 | 0.100 |
Why?
|
| Chromatography | 2 | 2012 | 187 | 0.100 |
Why?
|
| Antibodies, Bispecific | 1 | 1995 | 203 | 0.100 |
Why?
|
| Inflammation | 12 | 2005 | 10860 | 0.100 |
Why?
|
| Crystallography | 1 | 2012 | 110 | 0.100 |
Why?
|
| Killer Cells, Natural | 11 | 1995 | 2206 | 0.100 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 1194 | 0.100 |
Why?
|
| Chemokine CCL5 | 3 | 1998 | 213 | 0.100 |
Why?
|
| Chemotaxis | 4 | 2002 | 596 | 0.100 |
Why?
|
| Lymphatic System | 1 | 1994 | 250 | 0.100 |
Why?
|
| Viscosity | 3 | 2001 | 334 | 0.100 |
Why?
|
| Receptor Aggregation | 2 | 2004 | 71 | 0.100 |
Why?
|
| Scattering, Small Angle | 1 | 2012 | 61 | 0.100 |
Why?
|
| Wound Healing | 3 | 2013 | 2795 | 0.100 |
Why?
|
| Adjuvants, Immunologic | 2 | 1997 | 993 | 0.100 |
Why?
|
| Clone Cells | 12 | 1989 | 1671 | 0.100 |
Why?
|
| Bone Marrow Transplantation | 2 | 2018 | 2729 | 0.100 |
Why?
|
| Camurati-Engelmann Syndrome | 1 | 2011 | 2 | 0.100 |
Why?
|
| Weibel-Palade Bodies | 1 | 2011 | 19 | 0.100 |
Why?
|
| Immunologic Memory | 5 | 2012 | 1377 | 0.100 |
Why?
|
| Circular Dichroism | 1 | 2012 | 333 | 0.100 |
Why?
|
| Neutrophil Activation | 2 | 2006 | 180 | 0.100 |
Why?
|
| Crystallization | 1 | 2012 | 518 | 0.090 |
Why?
|
| Mice, Knockout | 7 | 2020 | 14456 | 0.090 |
Why?
|
| Argentina | 2 | 2002 | 249 | 0.090 |
Why?
|
| Latent TGF-beta Binding Proteins | 1 | 2011 | 45 | 0.090 |
Why?
|
| Actinin | 1 | 1992 | 165 | 0.090 |
Why?
|
| Chemical Phenomena | 7 | 1998 | 483 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2012 | 5020 | 0.090 |
Why?
|
| Sequence Homology, Nucleic Acid | 6 | 1992 | 1056 | 0.090 |
Why?
|
| Thymus Gland | 8 | 2002 | 1259 | 0.090 |
Why?
|
| Sepharose | 2 | 2001 | 100 | 0.090 |
Why?
|
| Cerebellum | 1 | 1998 | 1519 | 0.090 |
Why?
|
| Chromatography, Gel | 5 | 2006 | 631 | 0.090 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 1998 | 2425 | 0.090 |
Why?
|
| Cross Reactions | 7 | 1987 | 825 | 0.090 |
Why?
|
| Isoenzymes | 1 | 1995 | 1688 | 0.090 |
Why?
|
| England | 2 | 2002 | 533 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-kit | 4 | 1995 | 723 | 0.090 |
Why?
|
| X-Rays | 1 | 2011 | 309 | 0.090 |
Why?
|
| Chickens | 3 | 2000 | 842 | 0.090 |
Why?
|
| Lipid Bilayers | 5 | 1996 | 376 | 0.090 |
Why?
|
| Glycosylphosphatidylinositols | 5 | 2005 | 83 | 0.090 |
Why?
|
| Drosophila | 1 | 2018 | 1506 | 0.090 |
Why?
|
| Radioimmunoassay | 5 | 1988 | 860 | 0.090 |
Why?
|
| Axons | 1 | 2018 | 1677 | 0.090 |
Why?
|
| Bacterial Proteins | 2 | 2019 | 3830 | 0.090 |
Why?
|
| Complement C5a | 3 | 1997 | 98 | 0.080 |
Why?
|
| Fibroblasts | 5 | 2001 | 4162 | 0.080 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2011 | 305 | 0.080 |
Why?
|
| Platelet Aggregation | 2 | 2012 | 769 | 0.080 |
Why?
|
| Hot Temperature | 4 | 2013 | 1440 | 0.080 |
Why?
|
| Activins | 1 | 2011 | 210 | 0.080 |
Why?
|
| Drug Stability | 2 | 2008 | 289 | 0.080 |
Why?
|
| Scattering, Radiation | 1 | 2011 | 482 | 0.080 |
Why?
|
| Antigen-Presenting Cells | 3 | 2012 | 960 | 0.080 |
Why?
|
| Nucleic Acid Hybridization | 5 | 1989 | 1305 | 0.080 |
Why?
|
| Cell Differentiation | 14 | 2001 | 11642 | 0.080 |
Why?
|
| Alkaline Phosphatase | 2 | 1994 | 855 | 0.080 |
Why?
|
| Mice, Mutant Strains | 5 | 2003 | 1748 | 0.080 |
Why?
|
| Pliability | 1 | 2008 | 57 | 0.080 |
Why?
|
| RNA Splicing | 3 | 1993 | 902 | 0.080 |
Why?
|
| Receptors, Antigen, T-Cell | 5 | 2012 | 2570 | 0.080 |
Why?
|
| Neurodegenerative Diseases | 1 | 2018 | 1088 | 0.080 |
Why?
|
| Lymphoid Tissue | 3 | 1999 | 444 | 0.080 |
Why?
|
| Catalytic Domain | 1 | 2011 | 698 | 0.080 |
Why?
|
| Phytohemagglutinins | 5 | 2006 | 164 | 0.080 |
Why?
|
| Genes, MHC Class II | 3 | 2012 | 433 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 4 | 1995 | 4521 | 0.080 |
Why?
|
| Optical Tweezers | 1 | 2009 | 82 | 0.080 |
Why?
|
| Plasmids | 5 | 2004 | 2267 | 0.080 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 3942 | 0.080 |
Why?
|
| Complement Factor B | 1 | 1988 | 56 | 0.080 |
Why?
|
| Skin | 3 | 2003 | 4482 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2004 | 2898 | 0.080 |
Why?
|
| Cattle | 2 | 2007 | 3801 | 0.080 |
Why?
|
| Lampreys | 1 | 2008 | 32 | 0.080 |
Why?
|
| Molecular Mimicry | 1 | 2009 | 210 | 0.080 |
Why?
|
| Yeasts | 2 | 2008 | 278 | 0.080 |
Why?
|
| Skin Diseases, Infectious | 1 | 1989 | 74 | 0.080 |
Why?
|
| Escherichia coli | 3 | 2003 | 4210 | 0.070 |
Why?
|
| Genes, Immunoglobulin | 2 | 1989 | 283 | 0.070 |
Why?
|
| Uronic Acids | 1 | 2007 | 17 | 0.070 |
Why?
|
| Leukemia, Monocytic, Acute | 2 | 1986 | 58 | 0.070 |
Why?
|
| Phosphatidylinositol Diacylglycerol-Lyase | 3 | 1995 | 19 | 0.070 |
Why?
|
| Microscopy, Immunoelectron | 4 | 1996 | 316 | 0.070 |
Why?
|
| Periodic Acid | 2 | 1998 | 17 | 0.070 |
Why?
|
| HIV-1 | 4 | 2001 | 6948 | 0.070 |
Why?
|
| Molecular Motor Proteins | 1 | 2008 | 105 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 6506 | 0.070 |
Why?
|
| Blood Flow Velocity | 1 | 2011 | 1378 | 0.070 |
Why?
|
| Lymphoma, T-Cell | 4 | 1998 | 308 | 0.070 |
Why?
|
| Endothelial Cells | 2 | 2012 | 3586 | 0.070 |
Why?
|
| Leukemia, Hairy Cell | 4 | 1988 | 82 | 0.070 |
Why?
|
| Chemokine CXCL10 | 3 | 1998 | 310 | 0.070 |
Why?
|
| Platelet Membrane Glycoprotein IIb | 1 | 2007 | 51 | 0.070 |
Why?
|
| SNARE Proteins | 1 | 2007 | 80 | 0.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2012 | 4408 | 0.070 |
Why?
|
| Immunophenotyping | 3 | 1998 | 1865 | 0.070 |
Why?
|
| Time Factors | 12 | 2004 | 40108 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2022 | 3458 | 0.070 |
Why?
|
| Metalloendopeptidases | 3 | 1998 | 386 | 0.070 |
Why?
|
| Rabbits | 8 | 1996 | 4730 | 0.070 |
Why?
|
| Chemokine CCL7 | 2 | 1996 | 30 | 0.070 |
Why?
|
| Phorbols | 1 | 1986 | 44 | 0.070 |
Why?
|
| Restriction Mapping | 2 | 2000 | 848 | 0.070 |
Why?
|
| Wiskott-Aldrich Syndrome Protein | 1 | 2007 | 163 | 0.070 |
Why?
|
| Monocyte Chemoattractant Proteins | 2 | 1996 | 48 | 0.070 |
Why?
|
| Membranes, Artificial | 3 | 1995 | 362 | 0.070 |
Why?
|
| Membrane Lipids | 1 | 1987 | 240 | 0.070 |
Why?
|
| Porosity | 1 | 2007 | 347 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 4 | 2001 | 4399 | 0.070 |
Why?
|
| Dose-Response Relationship, Immunologic | 5 | 1998 | 355 | 0.070 |
Why?
|
| Gene Expression Regulation | 5 | 2020 | 11906 | 0.070 |
Why?
|
| Phosphoric Diester Hydrolases | 3 | 1995 | 205 | 0.070 |
Why?
|
| Peptides, Cyclic | 1 | 2008 | 390 | 0.070 |
Why?
|
| Myosin Heavy Chains | 1 | 2008 | 403 | 0.060 |
Why?
|
| Quantum Dots | 1 | 2007 | 166 | 0.060 |
Why?
|
| Receptors, Cytokine | 2 | 1997 | 257 | 0.060 |
Why?
|
| Cell Separation | 5 | 2008 | 1718 | 0.060 |
Why?
|
| RNA, Viral | 1 | 1994 | 2868 | 0.060 |
Why?
|
| Quinazolines | 1 | 2012 | 1366 | 0.060 |
Why?
|
| Shear Strength | 1 | 2006 | 160 | 0.060 |
Why?
|
| HeLa Cells | 3 | 1998 | 3073 | 0.060 |
Why?
|
| Kidney | 6 | 2008 | 7072 | 0.060 |
Why?
|
| Lymphokines | 3 | 1988 | 905 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 2 | 2006 | 6059 | 0.060 |
Why?
|
| HL-60 Cells | 2 | 1996 | 364 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2012 | 4649 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2022 | 17071 | 0.060 |
Why?
|
| Endopeptidases | 2 | 2001 | 760 | 0.060 |
Why?
|
| Interferon Type I | 3 | 1986 | 568 | 0.060 |
Why?
|
| Cytochalasin B | 2 | 1996 | 74 | 0.060 |
Why?
|
| Rats, Inbred BN | 5 | 1982 | 229 | 0.060 |
Why?
|
| Elasticity | 2 | 1997 | 652 | 0.060 |
Why?
|
| Proteomics | 1 | 2018 | 3907 | 0.060 |
Why?
|
| Chelating Agents | 2 | 1996 | 380 | 0.060 |
Why?
|
| Mass Spectrometry | 1 | 2012 | 2195 | 0.060 |
Why?
|
| Immunity, Cellular | 4 | 1989 | 1557 | 0.060 |
Why?
|
| Capillaries | 2 | 2007 | 751 | 0.060 |
Why?
|
| Carbohydrate Metabolism | 2 | 1998 | 261 | 0.060 |
Why?
|
| src-Family Kinases | 1 | 2007 | 539 | 0.060 |
Why?
|
| Caveolins | 1 | 2004 | 102 | 0.060 |
Why?
|
| Calcium Signaling | 2 | 2012 | 734 | 0.060 |
Why?
|
| Integrin alpha2beta1 | 1 | 2004 | 17 | 0.060 |
Why?
|
| Platelet Activation | 3 | 1997 | 643 | 0.060 |
Why?
|
| Carbohydrate Sequence | 2 | 1995 | 411 | 0.060 |
Why?
|
| Chemistry | 6 | 1983 | 325 | 0.060 |
Why?
|
| Immunoglobulin kappa-Chains | 2 | 1982 | 171 | 0.060 |
Why?
|
| Autoradiography | 2 | 2001 | 723 | 0.060 |
Why?
|
| Cold Temperature | 2 | 1998 | 794 | 0.060 |
Why?
|
| Hemolysis | 2 | 1985 | 408 | 0.060 |
Why?
|
| Egtazic Acid | 1 | 2003 | 165 | 0.060 |
Why?
|
| Immunoblotting | 2 | 1998 | 1644 | 0.050 |
Why?
|
| Contractile Proteins | 1 | 2004 | 240 | 0.050 |
Why?
|
| Luminescent Proteins | 2 | 2003 | 839 | 0.050 |
Why?
|
| EF Hand Motifs | 2 | 2000 | 19 | 0.050 |
Why?
|
| Glutathione Transferase | 2 | 2004 | 563 | 0.050 |
Why?
|
| Vitronectin | 2 | 2012 | 40 | 0.050 |
Why?
|
| Nanostructures | 1 | 2008 | 549 | 0.050 |
Why?
|
| Phagocytes | 2 | 1985 | 292 | 0.050 |
Why?
|
| Basement Membrane | 2 | 2003 | 348 | 0.050 |
Why?
|
| Lymph Nodes | 8 | 2003 | 3456 | 0.050 |
Why?
|
| Fungal Proteins | 1 | 2007 | 901 | 0.050 |
Why?
|
| Staining and Labeling | 1 | 2007 | 1072 | 0.050 |
Why?
|
| Metabolism, Inborn Errors | 1 | 1985 | 291 | 0.050 |
Why?
|
| Caveolin 1 | 1 | 2004 | 255 | 0.050 |
Why?
|
| Phosphoinositide Phospholipase C | 2 | 1995 | 28 | 0.050 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2004 | 683 | 0.050 |
Why?
|
| Dermatan Sulfate | 1 | 2002 | 43 | 0.050 |
Why?
|
| Methanosarcina | 1 | 2002 | 6 | 0.050 |
Why?
|
| Genome, Archaeal | 1 | 2002 | 21 | 0.050 |
Why?
|
| Growth Inhibitors | 1 | 1983 | 375 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5752 | 0.050 |
Why?
|
| DNA, Neoplasm | 1 | 1987 | 1739 | 0.050 |
Why?
|
| Lymphocyte Subsets | 1 | 2003 | 313 | 0.050 |
Why?
|
| Immunoglobulin Allotypes | 1 | 1982 | 52 | 0.050 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2003 | 198 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2006 | 1881 | 0.050 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 1 | 2001 | 22 | 0.050 |
Why?
|
| Nobel Prize | 1 | 2002 | 46 | 0.050 |
Why?
|
| Erythrocyte Membrane | 3 | 1987 | 428 | 0.050 |
Why?
|
| Ascitic Fluid | 5 | 1983 | 189 | 0.050 |
Why?
|
| Isoleucine | 1 | 2001 | 111 | 0.050 |
Why?
|
| rho-Associated Kinases | 1 | 2003 | 291 | 0.050 |
Why?
|
| Immunologic Techniques | 3 | 1997 | 212 | 0.050 |
Why?
|
| Homoserine | 1 | 2001 | 12 | 0.050 |
Why?
|
| Cyanogen Bromide | 1 | 2001 | 75 | 0.050 |
Why?
|
| Immunosorbents | 1 | 1981 | 21 | 0.050 |
Why?
|
| Swine | 2 | 2011 | 5986 | 0.050 |
Why?
|
| Staphylococcal Protein A | 1 | 2001 | 39 | 0.050 |
Why?
|
| Octoxynol | 1 | 2001 | 76 | 0.050 |
Why?
|
| Genetic Code | 1 | 1981 | 139 | 0.050 |
Why?
|
| Peptide Mapping | 2 | 1995 | 259 | 0.050 |
Why?
|
| 4-Butyrolactone | 1 | 2001 | 60 | 0.050 |
Why?
|
| Ficoll | 1 | 2001 | 39 | 0.050 |
Why?
|
| Plasmacytoma | 4 | 1983 | 171 | 0.050 |
Why?
|
| Phenotype | 9 | 2003 | 16716 | 0.050 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2003 | 415 | 0.050 |
Why?
|
| Sialic Acids | 3 | 1994 | 119 | 0.050 |
Why?
|
| Transcription Factors | 3 | 2011 | 12130 | 0.050 |
Why?
|
| Surface Properties | 2 | 2001 | 1152 | 0.050 |
Why?
|
| Thioglycolates | 4 | 1985 | 37 | 0.050 |
Why?
|
| Lovastatin | 1 | 2001 | 114 | 0.040 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2001 | 463 | 0.040 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2003 | 250 | 0.040 |
Why?
|
| Peyer's Patches | 2 | 2003 | 120 | 0.040 |
Why?
|
| Gene Expression | 4 | 2002 | 7582 | 0.040 |
Why?
|
| Anti-HIV Agents | 1 | 1996 | 4561 | 0.040 |
Why?
|
| RNA | 2 | 2006 | 2716 | 0.040 |
Why?
|
| Isoantibodies | 5 | 1991 | 681 | 0.040 |
Why?
|
| Isoelectric Focusing | 5 | 1986 | 148 | 0.040 |
Why?
|
| Cell Polarity | 1 | 2003 | 636 | 0.040 |
Why?
|
| Leucine | 1 | 2001 | 547 | 0.040 |
Why?
|
| Cell Lineage | 2 | 1999 | 2573 | 0.040 |
Why?
|
| Transcription, Genetic | 5 | 2002 | 7600 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 2001 | 1079 | 0.040 |
Why?
|
| Genetic Vectors | 2 | 2005 | 3400 | 0.040 |
Why?
|
| Valine | 1 | 2001 | 410 | 0.040 |
Why?
|
| Genetic Engineering | 1 | 2005 | 933 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2008 | 8924 | 0.040 |
Why?
|
| Cadherins | 1 | 2004 | 900 | 0.040 |
Why?
|
| Cell-Free System | 2 | 2001 | 339 | 0.040 |
Why?
|
| Sequence Analysis | 2 | 1997 | 240 | 0.040 |
Why?
|
| Mice, Inbred DBA | 7 | 1994 | 624 | 0.040 |
Why?
|
| Glutamine | 1 | 2003 | 575 | 0.040 |
Why?
|
| Hematopoiesis | 2 | 1999 | 2060 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 2004 | 760 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2004 | 1130 | 0.040 |
Why?
|
| Cryoelectron Microscopy | 1 | 2023 | 645 | 0.040 |
Why?
|
| Ribonucleoproteins | 1 | 2001 | 359 | 0.040 |
Why?
|
| Antilymphocyte Serum | 1 | 1981 | 492 | 0.040 |
Why?
|
| Sialomucins | 2 | 1995 | 18 | 0.040 |
Why?
|
| Alanine | 1 | 2001 | 613 | 0.040 |
Why?
|
| Species Specificity | 6 | 2004 | 2406 | 0.040 |
Why?
|
| Forssman Antigen | 1 | 1978 | 6 | 0.040 |
Why?
|
| Neurons | 1 | 1998 | 9521 | 0.040 |
Why?
|
| Salivary Glands | 1 | 2020 | 231 | 0.040 |
Why?
|
| Models, Immunological | 1 | 2001 | 517 | 0.040 |
Why?
|
| Fetal Tissue Transplantation | 1 | 1999 | 139 | 0.040 |
Why?
|
| Receptors, IgG | 4 | 1989 | 559 | 0.040 |
Why?
|
| Exons | 2 | 1998 | 2393 | 0.040 |
Why?
|
| Research Personnel | 1 | 2023 | 589 | 0.040 |
Why?
|
| Receptors, LDL | 1 | 2001 | 492 | 0.040 |
Why?
|
| Receptors, CCR3 | 1 | 1998 | 61 | 0.040 |
Why?
|
| H-2 Antigens | 4 | 1983 | 359 | 0.040 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1998 | 152 | 0.040 |
Why?
|
| Chemistry, Physical | 1 | 1998 | 152 | 0.040 |
Why?
|
| Bone Marrow | 6 | 1997 | 2916 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2003 | 1150 | 0.040 |
Why?
|
| Chemokine CCL3 | 1 | 1998 | 84 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2012 | 3112 | 0.040 |
Why?
|
| Diffusion Chambers, Culture | 1 | 1997 | 49 | 0.040 |
Why?
|
| Chemotactic Factors, Eosinophil | 1 | 1997 | 40 | 0.040 |
Why?
|
| Thrombasthenia | 1 | 1997 | 21 | 0.040 |
Why?
|
| Microtubules | 1 | 2003 | 1064 | 0.040 |
Why?
|
| Papain | 7 | 1983 | 66 | 0.040 |
Why?
|
| Chemokine CCL11 | 1 | 1997 | 127 | 0.040 |
Why?
|
| Chimera | 1 | 1999 | 455 | 0.040 |
Why?
|
| Glycoside Hydrolases | 2 | 1988 | 135 | 0.040 |
Why?
|
| Protein Transport | 2 | 2019 | 1939 | 0.040 |
Why?
|
| Mammals | 1 | 2023 | 1126 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2003 | 1967 | 0.040 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2022 | 539 | 0.040 |
Why?
|
| Bronchial Hyperreactivity | 1 | 1999 | 300 | 0.040 |
Why?
|
| Cytoplasmic Granules | 3 | 1993 | 573 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2004 | 1651 | 0.040 |
Why?
|
| Dogs | 2 | 1996 | 3824 | 0.040 |
Why?
|
| Physical Stimulation | 1 | 1999 | 514 | 0.030 |
Why?
|
| Respiratory Hypersensitivity | 1 | 1999 | 271 | 0.030 |
Why?
|
| Heart Arrest, Induced | 1 | 1998 | 359 | 0.030 |
Why?
|
| Bacterial Infections | 4 | 1986 | 1387 | 0.030 |
Why?
|
| Animals, Newborn | 2 | 2002 | 2677 | 0.030 |
Why?
|
| Chymotrypsin | 1 | 1996 | 136 | 0.030 |
Why?
|
| Chemokine CXCL1 | 1 | 1997 | 102 | 0.030 |
Why?
|
| Enterotoxins | 2 | 1995 | 366 | 0.030 |
Why?
|
| Lymphocyte Culture Test, Mixed | 2 | 1995 | 511 | 0.030 |
Why?
|
| Monokines | 1 | 1996 | 71 | 0.030 |
Why?
|
| Neutralization Tests | 2 | 2002 | 735 | 0.030 |
Why?
|
| Leukocyte-Adhesion Deficiency Syndrome | 1 | 1996 | 22 | 0.030 |
Why?
|
| Databases, Protein | 1 | 2018 | 391 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2006 | 1836 | 0.030 |
Why?
|
| Intracellular Membranes | 2 | 1987 | 386 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2003 | 10737 | 0.030 |
Why?
|
| Borohydrides | 1 | 1996 | 31 | 0.030 |
Why?
|
| Schiff Bases | 1 | 1996 | 22 | 0.030 |
Why?
|
| Osmotic Pressure | 1 | 1996 | 135 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1997 | 363 | 0.030 |
Why?
|
| Culture Media, Conditioned | 2 | 1997 | 520 | 0.030 |
Why?
|
| Fucosyltransferases | 1 | 1996 | 118 | 0.030 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2001 | 396 | 0.030 |
Why?
|
| Chemokine CCL8 | 1 | 1995 | 17 | 0.030 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 1996 | 138 | 0.030 |
Why?
|
| Differential Threshold | 1 | 1996 | 80 | 0.030 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 1996 | 67 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 5695 | 0.030 |
Why?
|
| Interleukin-2 | 6 | 2001 | 1894 | 0.030 |
Why?
|
| DNA Mutational Analysis | 2 | 2001 | 4112 | 0.030 |
Why?
|
| Cytotoxicity Tests, Immunologic | 5 | 1985 | 317 | 0.030 |
Why?
|
| Platelet Adhesiveness | 1 | 1996 | 154 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2004 | 2445 | 0.030 |
Why?
|
| Antibody Formation | 2 | 1985 | 1392 | 0.030 |
Why?
|
| Superantigens | 1 | 1995 | 124 | 0.030 |
Why?
|
| Terminology as Topic | 2 | 1994 | 1536 | 0.030 |
Why?
|
| Intercellular Junctions | 1 | 1996 | 198 | 0.030 |
Why?
|
| Teratoma | 1 | 1978 | 402 | 0.030 |
Why?
|
| Spodoptera | 1 | 1995 | 140 | 0.030 |
Why?
|
| Polymorphism, Genetic | 2 | 1987 | 4249 | 0.030 |
Why?
|
| Phospholipase C gamma | 1 | 1995 | 130 | 0.030 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1996 | 425 | 0.030 |
Why?
|
| Coturnix | 1 | 1995 | 22 | 0.030 |
Why?
|
| Activated-Leukocyte Cell Adhesion Molecule | 1 | 1995 | 21 | 0.030 |
Why?
|
| Mice, Inbred Strains | 4 | 1998 | 1769 | 0.030 |
Why?
|
| Clonal Anergy | 1 | 1995 | 169 | 0.030 |
Why?
|
| Subcellular Fractions | 3 | 1994 | 528 | 0.030 |
Why?
|
| Isomerism | 1 | 1995 | 197 | 0.030 |
Why?
|
| Immunomagnetic Separation | 1 | 1995 | 78 | 0.030 |
Why?
|
| Growth Substances | 1 | 1997 | 758 | 0.030 |
Why?
|
| Virus Replication | 4 | 2001 | 2458 | 0.030 |
Why?
|
| Cell Fusion | 3 | 1981 | 294 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2004 | 1704 | 0.030 |
Why?
|
| Biopolymers | 1 | 1995 | 181 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2002 | 2667 | 0.030 |
Why?
|
| Mesocricetus | 2 | 1986 | 256 | 0.030 |
Why?
|
| United States | 1 | 2022 | 72920 | 0.030 |
Why?
|
| Videotape Recording | 1 | 1996 | 333 | 0.030 |
Why?
|
| Cell Division | 3 | 2001 | 4466 | 0.030 |
Why?
|
| Giant Cells | 1 | 1994 | 187 | 0.030 |
Why?
|
| Lymphocyte Depletion | 1 | 1996 | 606 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1983 | 2838 | 0.030 |
Why?
|
| Blood Circulation | 1 | 1995 | 248 | 0.030 |
Why?
|
| Microfluidics | 1 | 2019 | 651 | 0.030 |
Why?
|
| Androstadienes | 1 | 1995 | 347 | 0.030 |
Why?
|
| Rhodococcus equi | 1 | 1993 | 16 | 0.030 |
Why?
|
| Phosphorylation | 3 | 1995 | 8292 | 0.030 |
Why?
|
| Glycoconjugates | 1 | 1994 | 87 | 0.030 |
Why?
|
| Computational Biology | 1 | 2005 | 3565 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 1983 | 3227 | 0.030 |
Why?
|
| Immunoglobulin Constant Regions | 1 | 1993 | 58 | 0.030 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2001 | 1276 | 0.030 |
Why?
|
| Cortactin | 1 | 2013 | 28 | 0.030 |
Why?
|
| Synovial Fluid | 1 | 1995 | 386 | 0.030 |
Why?
|
| Actin-Related Protein 2-3 Complex | 1 | 2013 | 59 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2001 | 14645 | 0.030 |
Why?
|
| Mice, Transgenic | 3 | 2001 | 9540 | 0.030 |
Why?
|
| Leukocytosis | 1 | 1994 | 249 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2001 | 1883 | 0.030 |
Why?
|
| Interleukin-3 | 1 | 1994 | 423 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2001 | 2495 | 0.030 |
Why?
|
| Structural Homology, Protein | 1 | 2012 | 86 | 0.030 |
Why?
|
| Arthritis, Infectious | 1 | 1996 | 347 | 0.030 |
Why?
|
| Phorbol Esters | 2 | 1989 | 108 | 0.030 |
Why?
|
| Chemokine CCL21 | 2 | 2002 | 49 | 0.020 |
Why?
|
| 1-Deoxynojirimycin | 1 | 1992 | 19 | 0.020 |
Why?
|
| HLA-DR Antigens | 4 | 1997 | 608 | 0.020 |
Why?
|
| Brain | 2 | 2018 | 27177 | 0.020 |
Why?
|
| Time-Lapse Imaging | 1 | 2013 | 194 | 0.020 |
Why?
|
| Mice, Inbred A | 2 | 1982 | 244 | 0.020 |
Why?
|
| Receptors, CCR7 | 2 | 2002 | 105 | 0.020 |
Why?
|
| Gene Library | 1 | 1995 | 1066 | 0.020 |
Why?
|
| Bacterial Adhesion | 1 | 1993 | 305 | 0.020 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2013 | 246 | 0.020 |
Why?
|
| Capsid | 1 | 1994 | 435 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2020 | 1889 | 0.020 |
Why?
|
| Glucosamine | 1 | 1992 | 128 | 0.020 |
Why?
|
| Female | 27 | 2020 | 396233 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 1997 | 1103 | 0.020 |
Why?
|
| Software | 1 | 2005 | 4463 | 0.020 |
Why?
|
| Interleukins | 1 | 1996 | 789 | 0.020 |
Why?
|
| Leishmania | 1 | 1992 | 75 | 0.020 |
Why?
|
| Tissue Distribution | 3 | 1985 | 2271 | 0.020 |
Why?
|
| Cell Compartmentation | 2 | 1993 | 383 | 0.020 |
Why?
|
| Antigens, Viral | 2 | 2001 | 995 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2006 | 5089 | 0.020 |
Why?
|
| Eye Proteins | 1 | 1995 | 628 | 0.020 |
Why?
|
| Immunoglobulin M | 3 | 1986 | 1527 | 0.020 |
Why?
|
| Herpesvirus 4, Human | 2 | 1988 | 1077 | 0.020 |
Why?
|
| Protein Unfolding | 1 | 2011 | 57 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 1995 | 1885 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 1468 | 0.020 |
Why?
|
| Ischemic Attack, Transient | 1 | 1996 | 871 | 0.020 |
Why?
|
| Graft Rejection | 2 | 1998 | 4504 | 0.020 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1989 | 99 | 0.020 |
Why?
|
| Proline | 2 | 2004 | 453 | 0.020 |
Why?
|
| Bucladesine | 1 | 1989 | 117 | 0.020 |
Why?
|
| Liver | 2 | 2023 | 7559 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 1996 | 2221 | 0.020 |
Why?
|
| Genetic Linkage | 3 | 2003 | 2342 | 0.020 |
Why?
|
| Male | 25 | 2009 | 363935 | 0.020 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 1 | 1989 | 31 | 0.020 |
Why?
|
| Complement Pathway, Classical | 1 | 1989 | 82 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1996 | 1494 | 0.020 |
Why?
|
| Astrocytes | 1 | 1997 | 1353 | 0.020 |
Why?
|
| Bacteremia | 1 | 1996 | 988 | 0.020 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 1989 | 152 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2001 | 3684 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2013 | 1336 | 0.020 |
Why?
|
| Lipopolysaccharides | 4 | 1994 | 2213 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 1 | 1989 | 548 | 0.020 |
Why?
|
| Reference Values | 2 | 1994 | 4909 | 0.020 |
Why?
|
| Immunosorbent Techniques | 2 | 1987 | 174 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 1995 | 1036 | 0.020 |
Why?
|
| Receptors, Vitronectin | 1 | 1988 | 48 | 0.020 |
Why?
|
| Staurosporine | 1 | 1989 | 240 | 0.020 |
Why?
|
| Synovial Membrane | 2 | 1989 | 512 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1989 | 416 | 0.020 |
Why?
|
| Liposomes | 2 | 1996 | 786 | 0.020 |
Why?
|
| Blood Platelet Disorders | 1 | 2009 | 60 | 0.020 |
Why?
|
| Alkaloids | 1 | 1989 | 191 | 0.020 |
Why?
|
| Colon | 1 | 1996 | 1797 | 0.020 |
Why?
|
| DNA, Recombinant | 1 | 1988 | 455 | 0.020 |
Why?
|
| DNA Probes | 1 | 1989 | 541 | 0.020 |
Why?
|
| Myocardial Ischemia | 1 | 1998 | 2132 | 0.020 |
Why?
|
| Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase | 1 | 1987 | 20 | 0.020 |
Why?
|
| Hexosaminidases | 1 | 1987 | 45 | 0.020 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2008 | 157 | 0.020 |
Why?
|
| Trypsin | 1 | 1988 | 487 | 0.020 |
Why?
|
| Shock, Septic | 1 | 1994 | 771 | 0.020 |
Why?
|
| Forecasting | 1 | 1997 | 2936 | 0.020 |
Why?
|
| Peroxidases | 1 | 1987 | 134 | 0.020 |
Why?
|
| Mast-Cell Sarcoma | 2 | 1986 | 46 | 0.020 |
Why?
|
| Epidermis | 2 | 1988 | 536 | 0.020 |
Why?
|
| Viral Matrix Proteins | 1 | 1988 | 192 | 0.020 |
Why?
|
| Complement C5 | 1 | 1987 | 99 | 0.020 |
Why?
|
| Bromelains | 1 | 1987 | 9 | 0.020 |
Why?
|
| Phenylalanine | 1 | 2009 | 367 | 0.020 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2007 | 99 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 1993 | 2003 | 0.020 |
Why?
|
| Synovitis | 1 | 1989 | 209 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 1996 | 1393 | 0.020 |
Why?
|
| Multiple Myeloma | 3 | 1980 | 5189 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 1993 | 978 | 0.020 |
Why?
|
| Lymphotoxin-alpha | 1 | 1987 | 94 | 0.020 |
Why?
|
| Ischemia | 1 | 1996 | 1904 | 0.020 |
Why?
|
| Protein Biosynthesis | 2 | 2002 | 2091 | 0.020 |
Why?
|
| Nitrophenols | 1 | 2007 | 169 | 0.020 |
Why?
|
| Chromosomes, Human, 16-18 | 1 | 1986 | 32 | 0.020 |
Why?
|
| Chromosomes, Human, 21-22 and Y | 1 | 1986 | 45 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2012 | 733 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 1999 | 2417 | 0.020 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2007 | 182 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2019 | 3466 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 1991 | 811 | 0.020 |
Why?
|
| Immunologic Capping | 1 | 1986 | 29 | 0.020 |
Why?
|
| Polyribosomes | 1 | 1986 | 109 | 0.020 |
Why?
|
| Peptones | 2 | 1985 | 5 | 0.020 |
Why?
|
| Immunohistochemistry | 4 | 1998 | 11035 | 0.020 |
Why?
|
| Cell Transformation, Viral | 2 | 1984 | 527 | 0.020 |
Why?
|
| Antigen Presentation | 1 | 2012 | 1250 | 0.020 |
Why?
|
| Phosphotyrosine | 1 | 2007 | 459 | 0.020 |
Why?
|
| Phagocyte Bactericidal Dysfunction | 1 | 1986 | 8 | 0.020 |
Why?
|
| Colony-Stimulating Factors | 1 | 1986 | 218 | 0.020 |
Why?
|
| Lung | 2 | 2003 | 10063 | 0.020 |
Why?
|
| Introns | 1 | 1989 | 965 | 0.020 |
Why?
|
| Leukotriene B4 | 1 | 1987 | 281 | 0.020 |
Why?
|
| Mice, Inbred AKR | 3 | 1999 | 103 | 0.020 |
Why?
|
| Concanavalin A | 2 | 1985 | 189 | 0.020 |
Why?
|
| Endonucleases | 1 | 1989 | 372 | 0.020 |
Why?
|
| Beta-Globulins | 3 | 1974 | 27 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 1995 | 2877 | 0.020 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 1989 | 481 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2013 | 1405 | 0.020 |
Why?
|
| West Nile virus | 1 | 1986 | 77 | 0.020 |
Why?
|
| Heart | 1 | 1998 | 4419 | 0.020 |
Why?
|
| Goats | 1 | 1985 | 166 | 0.020 |
Why?
|
| Culture Techniques | 1 | 1986 | 515 | 0.020 |
Why?
|
| Saphenous Vein | 1 | 1988 | 519 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2013 | 2144 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 1996 | 4780 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 1996 | 2100 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1986 | 456 | 0.010 |
Why?
|
| Colony-Forming Units Assay | 1 | 1985 | 351 | 0.010 |
Why?
|
| Information Systems | 1 | 1987 | 400 | 0.010 |
Why?
|
| Sodium Dodecyl Sulfate | 3 | 1985 | 123 | 0.010 |
Why?
|
| Organ Specificity | 3 | 1998 | 1966 | 0.010 |
Why?
|
| Profilins | 1 | 2004 | 65 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1986 | 563 | 0.010 |
Why?
|
| Ubiquitin | 1 | 2009 | 840 | 0.010 |
Why?
|
| beta 2-Microglobulin | 4 | 1981 | 330 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 1998 | 3307 | 0.010 |
Why?
|
| Peroxidase | 2 | 1998 | 610 | 0.010 |
Why?
|
| Neoplasms, Experimental | 2 | 1980 | 1227 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2001 | 9601 | 0.010 |
Why?
|
| Edema | 1 | 1988 | 763 | 0.010 |
Why?
|
| Blood Proteins | 1 | 1989 | 1186 | 0.010 |
Why?
|
| Collagen | 1 | 2012 | 2617 | 0.010 |
Why?
|
| Tretinoin | 1 | 1986 | 524 | 0.010 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 1983 | 81 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2007 | 1751 | 0.010 |
Why?
|
| Rats, Inbred Lew | 2 | 1983 | 1167 | 0.010 |
Why?
|
| Lipoproteins, LDL | 1 | 1986 | 642 | 0.010 |
Why?
|
| Biological Evolution | 1 | 1989 | 1075 | 0.010 |
Why?
|
| Rats, Inbred WF | 1 | 1982 | 139 | 0.010 |
Why?
|
| Luciferases | 1 | 2004 | 712 | 0.010 |
Why?
|
| Interferons | 1 | 1986 | 714 | 0.010 |
Why?
|
| Mesentery | 1 | 2003 | 200 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 1995 | 4213 | 0.010 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2004 | 390 | 0.010 |
Why?
|
| Lymphocyte Cooperation | 1 | 1982 | 112 | 0.010 |
Why?
|
| Gene Expression Regulation, Archaeal | 1 | 2002 | 3 | 0.010 |
Why?
|
| Langerhans Cells | 1 | 1983 | 169 | 0.010 |
Why?
|
| Euryarchaeota | 1 | 2002 | 8 | 0.010 |
Why?
|
| Chemokine CCL19 | 1 | 2002 | 37 | 0.010 |
Why?
|
| Adult | 13 | 2009 | 223139 | 0.010 |
Why?
|
| Nitrogen Fixation | 1 | 2002 | 66 | 0.010 |
Why?
|
| Electrophoresis | 3 | 1977 | 226 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 2 | 1995 | 3743 | 0.010 |
Why?
|
| Replication Origin | 1 | 2002 | 77 | 0.010 |
Why?
|
| Hemolytic Plaque Technique | 1 | 1981 | 59 | 0.010 |
Why?
|
| Keratinocytes | 1 | 2006 | 861 | 0.010 |
Why?
|
| Tritium | 3 | 1977 | 702 | 0.010 |
Why?
|
| Haploidy | 1 | 1981 | 128 | 0.010 |
Why?
|
| Leukemia, Experimental | 1 | 1982 | 224 | 0.010 |
Why?
|
| Hydrogen | 1 | 2002 | 168 | 0.010 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1987 | 975 | 0.010 |
Why?
|
| Lectins, C-Type | 1 | 2004 | 592 | 0.010 |
Why?
|
| Transcription Factor AP-2 | 1 | 2001 | 78 | 0.010 |
Why?
|
| Kidney Glomerulus | 1 | 1983 | 567 | 0.010 |
Why?
|
| Interleukin-15 | 1 | 2001 | 186 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 1993 | 3068 | 0.010 |
Why?
|
| Listeriosis | 1 | 1981 | 146 | 0.010 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1982 | 340 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 1989 | 1893 | 0.010 |
Why?
|
| Lymphoma | 2 | 1986 | 1896 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2012 | 2768 | 0.010 |
Why?
|
| 5' Untranslated Regions | 1 | 2001 | 255 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 2001 | 322 | 0.010 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 1982 | 287 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2002 | 788 | 0.010 |
Why?
|
| Apoptosis | 1 | 1995 | 9508 | 0.010 |
Why?
|
| Glycosaminoglycans | 1 | 2002 | 606 | 0.010 |
Why?
|
| Chemical Precipitation | 3 | 1984 | 173 | 0.010 |
Why?
|
| Computer Graphics | 1 | 2001 | 345 | 0.010 |
Why?
|
| Immunoassay | 1 | 1983 | 742 | 0.010 |
Why?
|
| Lipid Peroxides | 1 | 1998 | 73 | 0.010 |
Why?
|
| Carbon Radioisotopes | 2 | 1977 | 543 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 3424 | 0.010 |
Why?
|
| Carbon Monoxide | 1 | 2002 | 560 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2003 | 1041 | 0.010 |
Why?
|
| Cell Cycle | 1 | 1986 | 2920 | 0.010 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 1989 | 2156 | 0.010 |
Why?
|
| Mice, Inbred C3H | 3 | 1985 | 915 | 0.010 |
Why?
|
| Transplantation, Isogeneic | 1 | 1998 | 250 | 0.010 |
Why?
|
| Receptors, CCR4 | 1 | 1998 | 75 | 0.010 |
Why?
|
| Chemokine CXCL9 | 1 | 1998 | 137 | 0.010 |
Why?
|
| Iodoacetamide | 1 | 1977 | 33 | 0.010 |
Why?
|
| Ovary | 1 | 2002 | 961 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1999 | 752 | 0.010 |
Why?
|
| Antibodies, Neoplasm | 1 | 1979 | 282 | 0.010 |
Why?
|
| Lymphocyte Transfusion | 1 | 1998 | 236 | 0.010 |
Why?
|
| Chromosomes, Human, 6-12 and X | 1 | 1977 | 69 | 0.010 |
Why?
|
| Centrifugation | 1 | 1977 | 121 | 0.010 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 1997 | 38 | 0.010 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1987 | 1433 | 0.010 |
Why?
|
| Epithelium | 3 | 1987 | 1604 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1978 | 2077 | 0.010 |
Why?
|
| Ovalbumin | 1 | 1999 | 674 | 0.010 |
Why?
|
| Thrombosis | 1 | 2011 | 2955 | 0.010 |
Why?
|
| Receptors, CXCR3 | 1 | 1998 | 240 | 0.010 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 1997 | 68 | 0.010 |
Why?
|
| Child, Preschool | 5 | 1985 | 42511 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 1999 | 791 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1999 | 694 | 0.010 |
Why?
|
| Fetal Blood | 2 | 1997 | 1365 | 0.010 |
Why?
|
| Infant | 4 | 1985 | 36427 | 0.010 |
Why?
|
| Constriction | 1 | 1996 | 167 | 0.010 |
Why?
|
| Platelet Count | 1 | 1998 | 784 | 0.010 |
Why?
|
| Isotope Labeling | 1 | 1977 | 390 | 0.010 |
Why?
|
| Sulfhydryl Compounds | 1 | 1977 | 296 | 0.010 |
Why?
|
| Thymus Neoplasms | 1 | 1998 | 271 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1977 | 1300 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 1999 | 1154 | 0.010 |
Why?
|
| Integrin alpha5 | 1 | 1995 | 20 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 1998 | 939 | 0.010 |
Why?
|
| Integrin alpha2 | 1 | 1995 | 39 | 0.010 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 1995 | 220 | 0.010 |
Why?
|
| Gene Targeting | 1 | 1999 | 840 | 0.010 |
Why?
|
| Testis | 1 | 1978 | 782 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 2 | 1987 | 561 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 2 | 2001 | 5784 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2004 | 1725 | 0.010 |
Why?
|
| Receptors, CCR5 | 1 | 1997 | 491 | 0.010 |
Why?
|
| Polymers | 1 | 1982 | 1622 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1998 | 1605 | 0.010 |
Why?
|
| Chromium Radioisotopes | 1 | 1974 | 34 | 0.010 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1974 | 81 | 0.010 |
Why?
|
| Arginine | 1 | 1998 | 931 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 1986 | 3214 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2001 | 1801 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 1989 | 3637 | 0.010 |
Why?
|
| Leukemia, Lymphoid | 1 | 1974 | 307 | 0.010 |
Why?
|
| Phosphates | 1 | 1977 | 763 | 0.010 |
Why?
|
| Cerebral Arteries | 1 | 1996 | 490 | 0.010 |
Why?
|
| Serum Albumin, Bovine | 1 | 1974 | 319 | 0.010 |
Why?
|
| Staphylococcus aureus | 2 | 1995 | 1423 | 0.010 |
Why?
|
| Complement Pathway, Alternative | 1 | 1993 | 106 | 0.010 |
Why?
|
| Immune Sera | 3 | 1983 | 601 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1997 | 945 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1974 | 643 | 0.010 |
Why?
|
| Gold | 1 | 1996 | 480 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1993 | 765 | 0.010 |
Why?
|
| Coronary Circulation | 1 | 1998 | 1601 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1996 | 951 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 1998 | 1872 | 0.010 |
Why?
|
| Frameshift Mutation | 1 | 1993 | 392 | 0.010 |
Why?
|
| Glycosphingolipids | 1 | 1992 | 72 | 0.010 |
Why?
|
| Homozygote | 1 | 1996 | 1774 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2006 | 10433 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 1998 | 2890 | 0.010 |
Why?
|
| Syndrome | 2 | 1988 | 3270 | 0.010 |
Why?
|
| Oxygen | 1 | 2002 | 4247 | 0.010 |
Why?
|
| Adolescent | 4 | 1985 | 88819 | 0.010 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1997 | 1374 | 0.010 |
Why?
|
| Reperfusion Injury | 1 | 1996 | 1043 | 0.000 |
Why?
|
| Transforming Growth Factors | 1 | 1988 | 76 | 0.000 |
Why?
|
| Metallothionein | 1 | 1988 | 62 | 0.000 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1997 | 2205 | 0.000 |
Why?
|
| Second Messenger Systems | 1 | 1988 | 203 | 0.000 |
Why?
|
| HLA-DQ Antigens | 1 | 1988 | 190 | 0.000 |
Why?
|
| Tetanus Toxoid | 1 | 1988 | 186 | 0.000 |
Why?
|
| Blood Group Antigens | 1 | 1988 | 183 | 0.000 |
Why?
|
| HLA-DP Antigens | 1 | 1986 | 25 | 0.000 |
Why?
|
| Receptors, Transferrin | 1 | 1988 | 300 | 0.000 |
Why?
|
| Sulfur Radioisotopes | 1 | 1986 | 113 | 0.000 |
Why?
|
| Immunity, Innate | 1 | 1998 | 3079 | 0.000 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 1986 | 147 | 0.000 |
Why?
|
| Calcimycin | 1 | 1986 | 214 | 0.000 |
Why?
|
| Middle Aged | 3 | 1995 | 223083 | 0.000 |
Why?
|
| Blood Bactericidal Activity | 1 | 1985 | 123 | 0.000 |
Why?
|
| Macrophage-Activating Factors | 1 | 1985 | 21 | 0.000 |
Why?
|
| Ventricular Function, Left | 1 | 1998 | 3930 | 0.000 |
Why?
|
| Myocardium | 1 | 1998 | 4766 | 0.000 |
Why?
|
| Cerebrovascular Circulation | 1 | 1996 | 2675 | 0.000 |
Why?
|
| Staphylococcus epidermidis | 1 | 1985 | 121 | 0.000 |
Why?
|
| Intestinal Mucosa | 1 | 1996 | 3048 | 0.000 |
Why?
|
| Thymoma | 1 | 1986 | 186 | 0.000 |
Why?
|
| HLA-B7 Antigen | 1 | 1984 | 48 | 0.000 |
Why?
|
| Culture Media | 1 | 1986 | 889 | 0.000 |
Why?
|
| Glomerular Mesangium | 1 | 1984 | 97 | 0.000 |
Why?
|
| Drug Synergism | 1 | 1988 | 1754 | 0.000 |
Why?
|
| Microcirculation | 1 | 1989 | 1282 | 0.000 |
Why?
|
| Interphase | 1 | 1984 | 226 | 0.000 |
Why?
|
| HLA-A2 Antigen | 1 | 1984 | 207 | 0.000 |
Why?
|
| Genotype | 1 | 1998 | 13028 | 0.000 |
Why?
|
| Methionine | 1 | 1986 | 569 | 0.000 |
Why?
|
| Recurrence | 2 | 1986 | 8494 | 0.000 |
Why?
|
| Absorption | 1 | 1983 | 242 | 0.000 |
Why?
|
| BCG Vaccine | 1 | 1986 | 381 | 0.000 |
Why?
|
| Child | 3 | 1985 | 80573 | 0.000 |
Why?
|
| Alleles | 1 | 1993 | 6892 | 0.000 |
Why?
|
| Simplexvirus | 1 | 1984 | 805 | 0.000 |
Why?
|
| Mice, Inbred CBA | 1 | 1981 | 439 | 0.000 |
Why?
|
| Osteoarthritis | 1 | 1989 | 1051 | 0.000 |
Why?
|
| Blood Transfusion | 1 | 1987 | 1307 | 0.000 |
Why?
|
| Iodine Radioisotopes | 2 | 1974 | 1029 | 0.000 |
Why?
|
| Immunoenzyme Techniques | 1 | 1983 | 1695 | 0.000 |
Why?
|
| Listeria monocytogenes | 1 | 1981 | 245 | 0.000 |
Why?
|
| Incidence | 1 | 1998 | 21513 | 0.000 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1981 | 647 | 0.000 |
Why?
|
| Disease Susceptibility | 1 | 1985 | 1790 | 0.000 |
Why?
|
| Biological Products | 1 | 1988 | 947 | 0.000 |
Why?
|
| Autoantibodies | 1 | 1987 | 2114 | 0.000 |
Why?
|
| Pregnancy | 1 | 1997 | 30233 | 0.000 |
Why?
|
| Neoplasm Proteins | 1 | 1986 | 3594 | 0.000 |
Why?
|
| Immunoglobulin Fragments | 1 | 1974 | 83 | 0.000 |
Why?
|
| Aged | 2 | 1995 | 171219 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1997 | 21074 | 0.000 |
Why?
|
| Age Factors | 1 | 1986 | 18386 | 0.000 |
Why?
|
| Kidney Transplantation | 1 | 1983 | 4277 | 0.000 |
Why?
|